SG11202009259VA - Compositions - Google Patents

Compositions

Info

Publication number
SG11202009259VA
SG11202009259VA SG11202009259VA SG11202009259VA SG11202009259VA SG 11202009259V A SG11202009259V A SG 11202009259VA SG 11202009259V A SG11202009259V A SG 11202009259VA SG 11202009259V A SG11202009259V A SG 11202009259VA SG 11202009259V A SG11202009259V A SG 11202009259VA
Authority
SG
Singapore
Prior art keywords
compositions
Prior art date
Application number
SG11202009259VA
Inventor
Imke Elisabeth MULDER
Emma Raftis
Emma Elizabeth Clare Hennessy
Delphine Louise Claudette Laute-Caly
Philip Cowie
Original Assignee
4D Pharma Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1804384.4A external-priority patent/GB201804384D0/en
Priority claimed from GBGB1809953.1A external-priority patent/GB201809953D0/en
Priority claimed from GBGB1811900.8A external-priority patent/GB201811900D0/en
Priority claimed from GBGB1812378.6A external-priority patent/GB201812378D0/en
Priority claimed from GBGB1813423.9A external-priority patent/GB201813423D0/en
Priority claimed from GBGB1813444.5A external-priority patent/GB201813444D0/en
Priority claimed from GBGB1816834.4A external-priority patent/GB201816834D0/en
Priority claimed from GBGB1817641.2A external-priority patent/GB201817641D0/en
Priority claimed from GBGB1901199.8A external-priority patent/GB201901199D0/en
Priority claimed from GBGB1901218.6A external-priority patent/GB201901218D0/en
Priority claimed from GBGB1901993.4A external-priority patent/GB201901993D0/en
Priority claimed from GBGB1901992.6A external-priority patent/GB201901992D0/en
Application filed by 4D Pharma Res Ltd filed Critical 4D Pharma Res Ltd
Publication of SG11202009259VA publication Critical patent/SG11202009259VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
SG11202009259VA 2018-03-19 2019-03-19 Compositions SG11202009259VA (en)

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
GBGB1804384.4A GB201804384D0 (en) 2018-03-19 2018-03-19 Compositions
GBGB1809953.1A GB201809953D0 (en) 2018-06-18 2018-06-18 Compositions
EP18178350 2018-06-18
GBGB1811900.8A GB201811900D0 (en) 2018-07-20 2018-07-20 Compositions comprising bacterial strains
GBGB1812378.6A GB201812378D0 (en) 2018-07-30 2018-07-30 Compositions comprising bacterial strains
GBGB1813423.9A GB201813423D0 (en) 2018-08-17 2018-08-17 Compositions comprising bacterial strains
GBGB1813444.5A GB201813444D0 (en) 2018-08-17 2018-08-17 Compositions
GBGB1816834.4A GB201816834D0 (en) 2018-10-16 2018-10-16 Compositions
GBGB1817641.2A GB201817641D0 (en) 2018-10-29 2018-10-29 Compositions comprising bacterial strains
GBGB1901199.8A GB201901199D0 (en) 2019-01-29 2019-01-29 Compositions comprising bacterial strains
GBGB1901218.6A GB201901218D0 (en) 2019-01-29 2019-01-29 Compositions
GBGB1901993.4A GB201901993D0 (en) 2019-02-13 2019-02-13 Compositions
GBGB1901992.6A GB201901992D0 (en) 2019-02-13 2019-02-13 Compositions comprising bacterial strains
PCT/EP2019/056809 WO2019180000A1 (en) 2018-03-19 2019-03-19 Compositions

Publications (1)

Publication Number Publication Date
SG11202009259VA true SG11202009259VA (en) 2020-10-29

Family

ID=65955185

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11202009254YA SG11202009254YA (en) 2018-03-19 2019-03-19 Compositions comprising bacterial strains
SG11202009259VA SG11202009259VA (en) 2018-03-19 2019-03-19 Compositions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11202009254YA SG11202009254YA (en) 2018-03-19 2019-03-19 Compositions comprising bacterial strains

Country Status (23)

Country Link
US (3) US11419931B2 (en)
EP (3) EP4046644A1 (en)
JP (3) JP2021518129A (en)
KR (2) KR20210003096A (en)
CN (2) CN112004543A (en)
AU (2) AU2019238358A1 (en)
BR (2) BR112020018818A2 (en)
CA (2) CA3094297A1 (en)
DK (1) DK3768284T3 (en)
ES (1) ES2908826T3 (en)
HR (1) HRP20220368T1 (en)
HU (1) HUE058151T2 (en)
IL (2) IL277421B (en)
LT (1) LT3768284T (en)
MA (1) MA52128A (en)
MD (1) MD3768284T2 (en)
MX (2) MX2020009733A (en)
PL (1) PL3768284T3 (en)
RS (1) RS63090B1 (en)
SG (2) SG11202009254YA (en)
SI (1) SI3768284T1 (en)
TW (2) TW202003000A (en)
WO (2) WO2019180000A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4046644A1 (en) 2018-03-19 2022-08-24 4D Pharma Research Limited Compositions of entrecoccus flagellin for use in therapy
WO2021113500A2 (en) * 2019-12-03 2021-06-10 Board Of Regents, The University Of Texas System Combination therapies for the treatment of cancer
US20230256033A1 (en) * 2020-06-09 2023-08-17 Flagship Pioneering Innovations Vi, Llc Physiologically acceptable compositions containing microorganisms or microbial products
US20230111960A1 (en) * 2021-10-08 2023-04-13 Iowa State University Research Foundation, Inc. Use of dopamine producing products to increase vaccine efficacy
CN113999923A (en) * 2021-11-25 2022-02-01 上海金翌生物科技有限公司 Salix babylonica-Yuan-Tian syndrome marker microorganism and application thereof
CN115287243B (en) * 2022-04-15 2023-06-06 集美大学 Pseudomonas proteus flgK gene silencing strain and construction method thereof

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US5132418A (en) 1980-02-29 1992-07-21 University Patents, Inc. Process for preparing polynucleotides
US4500707A (en) 1980-02-29 1985-02-19 University Patents, Inc. Nucleosides useful in the preparation of polynucleotides
US4973679A (en) 1981-03-27 1990-11-27 University Patents, Inc. Process for oligonucleo tide synthesis using phosphormidite intermediates
US4668777A (en) 1981-03-27 1987-05-26 University Patents, Inc. Phosphoramidite nucleoside compounds
US4373071A (en) 1981-04-30 1983-02-08 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US5153319A (en) 1986-03-31 1992-10-06 University Patents, Inc. Process for preparing polynucleotides
US5262530A (en) 1988-12-21 1993-11-16 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
US5047524A (en) 1988-12-21 1991-09-10 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
JPH08259450A (en) 1995-03-17 1996-10-08 Nichinichi Seiyaku Kk Enhancer for production of interferon
US5700642A (en) 1995-05-22 1997-12-23 Sri International Oligonucleotide sizing using immobilized cleavable primers
EP0904784A1 (en) 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
GB0127916D0 (en) 2001-11-21 2002-01-16 Rowett Res Inst Method
US20040009937A1 (en) * 2002-01-31 2004-01-15 Wei Chen Methods and composition for delivering nucleic acids and/or proteins to the respiratory system
US20080025977A1 (en) 2003-04-14 2008-01-31 Arius Research, Inc. Cytotoxicity mediation of cells evidencing surface expression of CD59
US20060228369A1 (en) 2005-04-11 2006-10-12 Program For Appropriate Technology In Health Stabilization and preservation of temperature-sensitive vaccines
JP2007116991A (en) 2005-10-28 2007-05-17 Eternal Light General Institute Inc Functional food
ES2895666T3 (en) 2006-10-27 2022-02-22 Capsugel Belgium Nv Hydroxypropylmethylcellulose hard capsules and manufacturing process
EP1958647A1 (en) 2007-02-15 2008-08-20 Helmholtz-Zentrum für Infektionsforschung GmbH Pharmaceutical composition with bacteria for tumor treatment
ES2563242T3 (en) 2007-03-19 2016-03-11 Morishita Jintan Co., Ltd. Oral vaccine
JP2011519834A (en) * 2008-04-25 2011-07-14 インスティチュート フォー システムズ バイオロジー Flagellin polypeptide vaccine
MX2012004095A (en) * 2009-10-06 2012-09-12 Panacela Labs Inc Use of toll-like receptor and agonist for treating cancer.
EA026524B1 (en) 2011-01-10 2017-04-28 Общество С Ограниченной Ответственностью "Биолаб 612" USE OF Toll-LIKE RECEPTOR AGONIST FOR TREATING CANCER
ES2877100T3 (en) 2011-07-13 2021-11-16 Pharmaxis Ltd Provisioning Device Enhancements
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
ES2408279B1 (en) 2011-12-15 2014-09-09 Universidad De Las Palmas De Gran Canaria PROBIOTIC LACTIC ACID BACTERIA
FR2989002B1 (en) 2012-04-10 2015-05-15 Beepratte Lab COMPOSITIONS BASED ON PROBIOTICS AND A BEEPOLLEN / CLAY COMPLEX, THEIR PREPARATION AND THEIR USES IN NUTRITION AND THERAPEUTICS
EP2894985A4 (en) 2012-09-13 2016-09-28 Massachusetts Inst Technology Programmable drug delivery profiles of tumor-targeted bacteria
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
CN106029091B (en) * 2014-02-12 2020-02-11 特郎萨格以色列有限公司 Algal-based edible vaccines
GB201520502D0 (en) * 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
MA45287A (en) 2015-11-20 2018-08-22 4D Pharma Res Ltd COMPOSITIONS CONTAINING BACTERIAL STRAINS
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
TW201907931A (en) * 2017-05-24 2019-03-01 英商4D製藥研究有限公司 Composition comprising a bacterial strain
CN111356464A (en) 2017-07-05 2020-06-30 伊夫罗生物科学公司 Compositions and methods for treating cancer using bifidobacterium animalis subsp
EP3664824A1 (en) * 2017-08-10 2020-06-17 4D Pharma Research Limited Compositions comprising bacterial strains
EP4046644A1 (en) 2018-03-19 2022-08-24 4D Pharma Research Limited Compositions of entrecoccus flagellin for use in therapy

Also Published As

Publication number Publication date
US20220257745A1 (en) 2022-08-18
ES2908826T3 (en) 2022-05-04
RS63090B1 (en) 2022-04-29
CA3094297A1 (en) 2019-09-26
AU2019239048B2 (en) 2022-07-21
US11857614B2 (en) 2024-01-02
EP3768284A1 (en) 2021-01-27
TW202003000A (en) 2020-01-16
MA52128A (en) 2021-01-27
BR112020018818A2 (en) 2021-05-04
HUE058151T2 (en) 2022-07-28
AU2019239048A1 (en) 2020-11-05
WO2019180051A1 (en) 2019-09-26
KR20210003096A (en) 2021-01-11
CA3094139A1 (en) 2019-09-26
HRP20220368T1 (en) 2022-06-24
JP2021518414A (en) 2021-08-02
JP2023100747A (en) 2023-07-19
MX2020009733A (en) 2022-10-27
MD3768284T2 (en) 2022-06-30
BR112020019008A2 (en) 2020-12-29
CN112004543A (en) 2020-11-27
SI3768284T1 (en) 2022-04-29
PL3768284T3 (en) 2022-04-11
MX2020009736A (en) 2021-01-08
LT3768284T (en) 2022-04-11
DK3768284T3 (en) 2022-03-07
SG11202009254YA (en) 2020-10-29
EP4046644A1 (en) 2022-08-24
IL277421B (en) 2022-04-01
EP3768284B1 (en) 2022-01-05
IL277421A (en) 2020-11-30
IL277422A (en) 2020-11-30
KR102578117B1 (en) 2023-09-12
WO2019180000A1 (en) 2019-09-26
US20210138058A1 (en) 2021-05-13
CN111886018A (en) 2020-11-03
AU2019238358A1 (en) 2020-10-08
JP2021518129A (en) 2021-08-02
TW202003001A (en) 2020-01-16
EP3768285A1 (en) 2021-01-27
US20210169950A1 (en) 2021-06-10
US11419931B2 (en) 2022-08-23
KR20200134255A (en) 2020-12-01

Similar Documents

Publication Publication Date Title
GB201811312D0 (en) Compositions
GB2586745B (en) Compositions
SG11202104306XA (en) Compositions
SG11202009259VA (en) Compositions
GB201811100D0 (en) Composition
GB201810492D0 (en) Composition
GB201820878D0 (en) Composition
GB201812145D0 (en) Composition
GB201804434D0 (en) Composition
GB201803923D0 (en) Compositions
GB201901161D0 (en) Composition
GB201818827D0 (en) Composition
GB2570649B (en) Compositions
GB201819206D0 (en) Novel compositions
GB201805676D0 (en) Compositions
GB201819861D0 (en) Composition
GB201815032D0 (en) Composition
GB201809123D0 (en) Composition
GB201801596D0 (en) Composition
ZA202005658B (en) Compositions
PT3768284T (en) Compositions
GB201820233D0 (en) Compositions
GB201816834D0 (en) Compositions
GB201813444D0 (en) Compositions
GB201809953D0 (en) Compositions